United Therapeutics Corporation Stock price
Equities
UTHR
US91307C1027
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
234 USD | -0.77% | -6.23% | +6.40% |
Financials (USD)
Sales 2024 * | 2.7B | Sales 2025 * | 2.82B | Capitalization | 11.01B |
---|---|---|---|---|---|
Net income 2024 * | 1.2B | Net income 2025 * | 1.23B | EV / Sales 2024 * | 2.86 x |
Net cash position 2024 * | 3.3B | Net cash position 2025 * | 4.14B | EV / Sales 2025 * | 2.44 x |
P/E ratio 2024 * |
9.86
x | P/E ratio 2025 * |
9.56
x | Employees | 1,168 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.65% |
Latest transcript on United Therapeutics Corporation
1 day | -0.77% | ||
1 week | -3.74% | ||
Current month | +3.69% | ||
1 month | +8.96% | ||
3 months | -5.06% | ||
6 months | +6.23% | ||
Current year | +6.40% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 69 | 96-06-25 | |
President | 52 | 11-03-31 | |
James Edgemond
DFI | Director of Finance/CFO | 56 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 76 | 01-12-31 |
Chief Executive Officer | 69 | 96-06-25 | |
Tommy Thompson
BRD | Director/Board Member | 81 | 09-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.06% | 1 M€ | -.--% | - | |
2.87% | 2 M€ | +8.58% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 234 | -0.77% | 447,746 |
24-03-15 | 235.8 | -0.98% | 898,652 |
24-03-14 | 238.1 | -1.31% | 360,288 |
24-03-13 | 241.3 | -2.27% | 489,153 |
24-03-12 | 246.9 | -1.06% | 374,481 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.40% | 11.1B | |
+9.72% | 46B | |
+35.14% | 39.85B | |
+4.84% | 39.76B | |
-9.43% | 28.16B | |
+17.47% | 27.62B | |
-22.99% | 18.8B | |
+10.88% | 13.3B | |
+27.53% | 12.2B | |
-6.84% | 11.4B |